by BSPGHAN | Feb 29, 2020 | Quality Standards
The British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) has commissioned the Royal College of Paediatrics and Child Health (RCPCH) to deliver the National Audit of Quality Standards for Paediatric Gastroenterology, Hepatology and Nutrition (‘the PGHAN Audit’). We seek to work with clinicians throughout the UK to improve the health outcomes for children that require gastroenterology, hepatology and nutritional services.
The National Audit will be based on the 2017 Quality Standards for Paediatric Gastroenterology, Hepatology and Nutrition. The 2017 Quality Standards sought to improve the health outcomes and quality of life for all infants, children and young people with gastroenterology, liver or intestinal disorders by reducing the variation in care by clinicians and ensuring equitable services throughout the UK.
The National Audit will aim to define clinical pathways of paediatric gastroenterology, hepatology and nutritional services throughout the UK. We will collect and share data to support UK clinicians that require resources to improve their gastroenterology, hepatology and nutritional services.
Data Submission
Registration now open
The registration of the PGHAN
Audit lead will take approximately two minutes using https://tinyurl.com/PGHANAudit.
We would be extremely grateful
if you could encourage your local Health Board/Trust to identify a
PGHAN Audit lead(s) and
ask them to complete the registration form by 18 March 2020.
The audit will be released from April 2020.
Data and report will be released in July 2020.
Enquiries
If you have any further enquiries about the PGHAN Audit, please contact pghan.audit@rcpch.ac.uk
by BSPGHAN | Feb 23, 2020 | IBD, Research
Why is this project being done?
A recent project has investigated every RCT in IBD in both adults and children published globally since 1996 (the year the first publication guidance in the CONSORT statement were released). We found that 20% of studies have no sample size estimate to guide how many patients should be recruited to the project. However, for the studies that did calculate power, they used variable and often highly spurious figures of the difference between groups that they expected which leads low numbers of patients included. This has left many studies underpowered and impacts the entire evidence base, as we often see when completing systematic reviews. Guidance, based on actual observed effect sizes, could support trial designers and most importantly ensure funded studies are completed to an appropriate power.
What will participation involve?
We will ask you to attend a face to face session in one of five locations across the UK for approximately 2-4 hours with 5-12 other professionals working within IBD. We will present the actual data for effect size seen over trials in a number of different settings, categorised by disease (UC or CD), current state of activity (induction or remission studies), specific agents of study and age of patients. We will then ask you, based on the actual data presented and the quality and certainty of that data, to estimate what you would think a minimum and maximum likely effect size would be for a trial in a similar setting. Once all the sessions are complete, you will be invited to participate in a second and third stage online, consistent with a Delphi approach. This will present the data from all the sessions analysed and allow a national expert consensus to be reached and this paper published.
Who can get involved?
We are looking at a range of professionals involved with the care of IBD. This can involve consultants, specialist nurses, researchers and indeed patients. We are particular keen on those who have practical experience with a range of treatments with their patients and the success rates / impact of these with their patients, as this will allow practical expert view to enhance the decision making based on the data we represent. No research experience is needed.
Can you tell me more about the face to face session?
These will take place in February and March 2020 in London, Cardiff, Glasgow and Preston. We will have a local meeting space and provide refreshments and also reimburse travel up to £60.
How else can I get involved?
If participants are keen to support this work, they can discuss with our team and potentially support the analysis and write up of the project. We also invite anyone involved in this and other Cochrane works to contact us.
If you are interested in getting involved, please contact mgordon@uclan.ac.uk
